SISVEL
Europe’s leading patent pool operator has unveiled a new mission statement to accompany the presentation of a redesigned corporate image and website today. Sisvel’s message, “We power innovation,” replaces the previous “We protect ideas” slogan, as the firm places itself at the heart of the innovative activity that will drive the global economy for the remainder of the 21st century.
“We are proud to have built strong relationships with companies and research institutions that are dedicated to delivering world class technological solutions in areas such as connectivity, broadcasting and coding,” says Sisvel President Mattia Fogliacco. “Our commitment to them and to those who deploy their technologies is that we will do all we can to facilitate fair returns on R&D investments while speeding new products to market.”
Sisvel has dozens of partners, including the BBC, Dolby, GE, Huawei, Microsoft, Philips, RAI, Samsung and Sony. They hold pivotal patents that underpin key technologies in 5G, C-IoT, DVB-T2, VP9, AV1 and Wi-Fi 6. The firm has a reputation for building flexible, market-focused licensing programmes that benefit pool members who invest substantial sums in R&D, as well as the entities that implement the results of this work.
Founded by Roberto Dini in Italy in 1982, Sisvel now has offices across Europe, as well as in North America and Asia. It has created programmes that have returned billions of dollars to partners whose inventions underpin industries that enhance tens of millions of lives around the world.
“It is so gratifying to reflect on the success that Sisvel has enjoyed over the last four decades. I cannot wait to see what the coming years will bring,” says Mr Dini. “One thing is certain: we will be at the centre of whatever happens, offering solutions that are tailored to the markets we serve.”
The new website is the result of six months of development work. Its modern, dynamic visual language has been designed to encapsulate both the firm’s heritage and its future ambitions, says Giulia Dini, Sisvel’s Head of Communications.
“The updated brand messaging underscores Sisvel's 40 years of unwavering commitment to supporting innovation across diverse industries that drive the 21st-century economy, while highlighting the company's own spirit of creativity, flexibility and fairness,” Ms Dini adds.
The Sisvel website can be found at www.sisvel.com
About Sisvel
Sisvel is driven by a belief in the importance of collaboration, ingenuity and efficiency to bridge the needs of patent owners and those who wish to access their technologies. In a complex and constantly evolving marketplace, our guiding principle is to create a level playing field with the development and implementation of flexible, accessible, commercialisation solutions.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230919780984/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Zetagen Therapeutics to Present Preliminary Results from Phase 2 Clinical Trial Targeting Metastatic Breast Cancer to Bone at the 2025 San Antonio Breast Cancer Symposium4.11.2025 16:04:00 CET | Press release
Complete Response in all treated lesions: Patients completing the study showed CR via the MD Anderson Criteria and RECIST v1.1 with no active tumor detected on MRIFirst-of-its-kind single intratumoral injection for MBC to the spineTreated lesions showed full bone regeneration with reconstitution of trabecular bone, and no skeletal related events; mean lesion defect volume decreased by 87.9% at day 180.Therapeutic spread extended to nearby non-treated lesions, also achieving complete response within the same vertebral body Zetagen Therapeutics, a privately held clinical-stage biopharmaceutical company pioneering first-of-its-kind targeted therapies for both primary and metastatic breast cancer, announced today that its abstract titled “Single Intratumoral Drug Injection Yields Complete Response (CR) in Metastatic Breast Cancer (MBC) Bone Lesions”, has been accepted and will be presented at the 2025 San Antonio Breast Cancer Symposium (SABCS) on Wednesday, December 10, 2025. The abstract
ID5 Acquires TrueData, Combining Strengths to Create the Most Comprehensive Identity Solution for Digital Advertising4.11.2025 16:00:00 CET | Press release
Acquisition creates a global privacy-focused identity powerhouse and enhances value for partners through expanded capabilities ID5, the market-leading ID provider for digital advertising, has today announced the acquisition of TrueData, a top-tier US-based identity graph company. The deal represents a major step forward in ID5’s growth strategy, significantly strengthening its presence in the US and broadening the value it can deliver to partners worldwide. ID5, recognized as a global leader in the alternative ID space, has built a strong foothold in the US, where the majority of its clients and revenue originate. By bringing in TrueData’s graph, the company is expanding its operations in the US and strengthening its Adaptive Identity technology with new datasets and expertise. The combination of TrueData’s graph and expertise with the GDPR compliant ID5 Graph, and its scaled alternative ID creates a unique proposition in the market, connecting offline data with the largest online reac
Westlake Announces Proposed Offering of Senior Notes4.11.2025 15:15:00 CET | Press release
Westlake Corporation (NYSE: WLK) (“Westlake”) announced today the commencement of an underwritten public offering, subject to market and other conditions, of senior unsecured notes (the “Notes”) under its existing shelf registration statement. The timing of pricing and terms of the Notes are subject to market conditions and other factors. Westlake intends to use the net proceeds from the proposed public offering of the Notes to fund the repurchase of its outstanding 3.600% Senior Notes due 2026 (the “2026 Senior Notes”) pursuant to a concurrent cash tender offer (the “Tender Offer”) for any and all of the 2026 Senior Notes. Westlake anticipates using any remaining net proceeds to fund the purchase price of its pending acquisition of the global compounding solutions businesses of the ACI/Perplastic Group (the “ACI Acquisition”) and for general corporate purposes, including working capital management. The offering of the Notes is not contingent upon the successful completion of the Tende
Westlake Announces Cash Tender Offer4.11.2025 15:13:00 CET | Press release
Westlake Corporation (NYSE: WLK) (“Westlake”) announced today the commencement of a cash tender offer to purchase (the “Offer”) any and all of the outstanding 3.600% Senior Notes due 2026 (the “Notes”) as set forth in the table below. The tender offer is being made solely pursuant to the terms and conditions set forth in an Offer to Purchase, dated November 4, 2025 (the “Offer to Purchase”). Holders of the Notes are urged to carefully read the Offer to Purchase before making any decision with respect to the tender offer. The tender offer is not conditioned on any minimum amount of the Notes being tendered. Subject to applicable law, Westlake may amend, extend or terminate the tender offer in its sole discretion. Capitalized terms used but not defined in this announcement have the meanings given to them in the Offer to Purchase. Series of Notes CUSIP Numbers(1) Aggregate Principal Amount Outstanding U.S. Treasury Reference Security(2) Bloomberg Reference Page(2) Fixed Spread(3) 3.600% S
In-House Counsel Warn of Mounting Risks as Service of Process Volume Surges4.11.2025 15:00:00 CET | Press release
93% of in-house counsel say mass arbitration is increasing SOP risk and complexity59% report varying state requirements are driving compliance errors97% use AI for managing or analyzing SOP, yet 96% remain concerned about accuracy and speed The volume of service of process (SOP)—the legal procedure by which one party formally notifies another of a legal action—is surging across the U.S., amplifying operational pressure and compliance risk for in-house legal teams. This is according to a new nationwide study commissioned by CSC, industry-leading registered agent and compliance service provider. CSC surveyed 250 senior in-house counsel across the U.S. and found that rising SOP volume and growing concerns around data accuracy are intensifying both risk and workload pressure.1 Respondents cited data accuracy as a significant challenge to SOP management (61%), followed by rising SOP volume (56%). More than three-quarters (76%) said their departments are spending “too much” or “excessive” ti
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom